JPRN-UMIN000012745已完成2 期
Randomized controlled trial on the usefulness of ninjinyoeito (Kampo formula) for oxaliplatin-induced peripheral neuropathy and anemia (HOPE-2) - HOPE-2
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 52
研究概览
简要总结
injin7yoeito significantly ameliorated the grade of oxaliplatin-induced cumulative peripheral neuropathy.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Blood transfusion or G-CSF administration within 7 days 2. Pleural effusion, ascites, or pericardial effusion, necessary for drainage 3. double cancers 4. drug hypersensitivity 5. diabetic neuropathy 6. diabetes mellitus, necessary for insulin therapy
研究者
相似试验
已完成
不适用
Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral NeuropathyQuality of LifeChemotherapy-induced Peripheral NeuropathyNCT04913376Universitaire Ziekenhuizen KU Leuven66
已完成
不适用
Peripheral Nerve Stimulation to Reduce Hypoxic EventsApneaHypoventilationHypoxemiaNCT02554110Mayo Clinic80
已完成
3 期
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainParkinson's Disease With Severe PainNCT01439100Mundipharma Research GmbH & Co KG172
招募中
2 期
To protect peripheral oxaliplatin-related neuralgia by pregabalin in Kansai areaColorectal CancerJPRN-UMIN000010438Osaka City University Graduate School of Medicine Department of Surgical Oncology120
撤回
2 期
A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based ChemoChemotherapy-induced Peripheral NeuropathyNCT04492436Veloxis Pharmaceuticals